Eslovaquia - eslovaco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glenmark pharmaceuticals s.r.o., Česká republika - beklometazón - 14 - bronchodilatantia, antiasthmatica

Eslovaquia - eslovaco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glenmark pharmaceuticals s.r.o., Česká republika - beklometazón - 14 - bronchodilatantia, antiasthmatica

Eslovaquia - eslovaco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glenmark pharmaceuticals s.r.o., Česká republika - beklometazón - 14 - bronchodilatantia, antiasthmatica

Eslovaquia - eslovaco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glenmark pharmaceuticals s.r.o., Česká republika - beklometazón - 14 - bronchodilatantia, antiasthmatica

Unión Europea - eslovaco - EMA (European Medicines Agency)

albireo - odevixibat - cholestasis, intrahepatic - liečba žlčou a pečeňou - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 a 5.

Eslovaquia - eslovaco - ŠÚKL (Štátny ústav pre kontrolu liečiv)

lobsor pharmaceuticals ab, Švédsko - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica

Unión Europea - eslovaco - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - všetky ostatné terapeutické produkty - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Unión Europea - eslovaco - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidone - idiopatická pľúcna fibróza - imunosupresíva - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Unión Europea - eslovaco - EMA (European Medicines Agency)

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

Unión Europea - eslovaco - EMA (European Medicines Agency)

tad pharma gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotické činidlá - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.